Yunnan Botanee Bio-Technology Group Co.LTD

SZSE:300957 Stock Report

Market Cap: CN¥20.9b

Yunnan Botanee Bio-Technology GroupLTD Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Zhenyu Guo

Chief executive officer

CN¥5.0m

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership2.6%
Management average tenureno data
Board average tenure2.5yrs

Recent management updates

Recent updates

Earnings Troubles May Signal Larger Issues for Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Shareholders

Nov 02
Earnings Troubles May Signal Larger Issues for Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Shareholders

Is Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957) Trading At A 39% Discount?

Oct 19
Is Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957) Trading At A 39% Discount?

The Market Lifts Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957) Shares 26% But It Can Do More

Sep 27
The Market Lifts Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957) Shares 26% But It Can Do More

Is Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) A Risky Investment?

Sep 25
Is Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) A Risky Investment?

Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Will Pay A Smaller Dividend Than Last Year

Jun 03
Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Will Pay A Smaller Dividend Than Last Year

A Look At The Fair Value Of Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957)

May 24
A Look At The Fair Value Of Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957)

Yunnan Botanee Bio-Technology GroupLTD's (SZSE:300957) Sluggish Earnings Might Be Just The Beginning Of Its Problems

May 02
Yunnan Botanee Bio-Technology GroupLTD's (SZSE:300957) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Has A Pretty Healthy Balance Sheet

Feb 29
Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Has A Pretty Healthy Balance Sheet

CEO

Zhenyu Guo (61 yo)

no data

Tenure

CN¥5,000,000

Compensation

Mr. Zhenyu Guo serves as General Manager & Non-Independent Chairman of the Board at Yunnan Botanee Bio-Technology Group Co.LTD.


Board Members

NamePositionTenureCompensationOwnership
Zhenyu Guo
GM & Non-Independent Chairman of the Boardno dataCN¥5.00m2.62%
CN¥ 547.0m
Xiao Ma
Deputy GM & Non-Independent Director2.5yrsCN¥4.00mno data
Mei Zhang
Deputy GM & Director1.5yrsCN¥2.49mno data
Kui Zhou
Non-Independent Director2.5yrsno datano data
Shaoyang Gao
Non-Independent Director2.5yrsCN¥4.00mno data
Zhiwei Li
Independent Non-Executive Director2.5yrsCN¥200.00kno data
Wei Zhou
Non-Independent Director2.5yrsCN¥600.00kno data
Ao Wang
Independent Non-Executive Director2.5yrsCN¥200.00kno data
Ning Li
Independent Non-Executive Director2.5yrsCN¥200.00kno data
Shiru Yu
Non-Employee Supervisor2.5yrsno datano data
Lei Li
Non-Employee Supervisor2.5yrsno datano data
Zurong Yang
Employee Supervisorno datano datano data

2.5yrs

Average Tenure

51yo

Average Age

Experienced Board: 300957's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.